|
|
|
Volumn 22, Issue 137, 2013, Pages 105-107
|
|
New drugs and indications in 2012 Sluggish progress, timid measures to protect patients
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABIRATERONE;
ARGATROBAN;
BETA ALANINE;
DASATINIB;
DRONEDARONE;
EVEROLIMUS;
FLURBIPROFEN;
FUSIDIC ACID;
NEW DRUG;
PIRFENIDONE;
QUETIAPINE;
ROPINIROLE;
TRIMETAZIDINE;
ANGINA PECTORIS;
DRUG COST;
DRUG INDICATION;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG SAFETY;
FIBROSING ALVEOLITIS;
HEART ATRIUM FIBRILLATION;
HOT FLUSH;
HUMAN;
LEUKEMIA;
PATIENT SAFETY;
PROSTATE CANCER;
REIMBURSEMENT;
RESTLESS LEGS SYNDROME;
SHORT SURVEY;
DRUG APPROVAL;
DRUG INDUSTRY;
FRANCE;
HUMANS;
LEGISLATION, DRUG;
PHARMACEUTICAL PREPARATIONS;
SAFETY-BASED DRUG WITHDRAWALS;
|
|
EID: 84877906111
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (3)
|
|
References (0)
|